index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

120 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Butyrylcholinesterase Acetyltransferase Allele-specific silencing Myogenesis Treatment Myologie COVID-19 Biological sciences A-type lamins Cardiomyopathy Emery-Dreifuss muscular dystrophy Myopathies COL6A1 Lamin A/C LMNA gene Autophagosome maturation Lamin A/C nuclei Laminopathies Cardiology Lamin A/C Dilated cardiomyopathy Exome Laminopathy Clinical trial Mutations Hypermobile EDS COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Muscular dystrophy Cancer CSF protein Dystrophie musculaire C elegans Next generation sequencing LMNA Diagnosis BiP Myopathy Nuclear envelope LMNA gene Calcium handling Regeneration Alternative splicing Cardiac conduction system Skeletal muscle Lamins Duchenne muscular dystrophy Gene therapy RNA interference CRISPR Actionability Adult SMA CMTX Base de données FAIR Myotubes Mouse Allele-specific silencing therapy Cancer biomarkers Neuromuscular diseases LMNA-related congenital muscular dystrophy Muscle MRI Muscle Rare neuromuscular diseases Patient registry C2C12 Therapy Maladies rares Allele‐specific silencing therapy Treatment delay Angiotensin-converting enzyme inhibitor COL1A1 POPDC1 LGMD Laminopathie Emerin Muscle biopsy AAV VECTOR Ehlers‐Danlos Syndrome Connective tissue BVES Becker muscular dystrophy GNE Titin Maladies rares et orphelines Actionable gene Heart INPP5K Centronuclear myopathy Congenital muscular dystrophy IPSC AAV Errance diagnostique Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Rare diseases Muscular dystrophy MD Dynamin 2 Angiotensin-converting enzyme inhibitors Joint laxity A-type lamin Heart failure Biomarker Dystrophine